Evidence map›Paper›PMID 42208022›Full record

ArticleACS nano2026

Ultrasmall Ligand-Protected Ag

Divinah Manoharan, Kana Yamamoto, Li-Chan Chang, Chouma Kurihashi, Issey Osaka, Yin-Fen Liu, Siou-Wei Liang, Hideya Kawasaki, Wen-Pin Su, Chen-Sheng Yeh

Abstract read
In one paragraph

Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Divinah ManoharanDepartment of Chemistry, National Cheng Kung University, Tainan 701, Taiwan.ORCID 0000-0001-8208-5594
Kana YamamotoDepartment of Chemistry and Materials Engineering, Kansai University, 3-3-35 Yamate-cho, Suita, Osaka 564-8680, Japan.
Li-Chan ChangInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0000-0002-9953-5800
Chouma KurihashiDepartment of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama 939-0398, Japan.
Issey OsakaDepartment of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama 939-0398, Japan.
Yin-Fen LiuInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0009-0009-2437-1029
Siou-Wei LiangDepartment of Chemistry, National Cheng Kung University, Tainan 701, Taiwan.
Hideya KawasakiDepartment of Chemistry and Materials Engineering, Kansai University, 3-3-35 Yamate-cho, Suita, Osaka 564-8680, Japan.ORCID 0000-0003-2713-2057
Wen-Pin SuInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0000-0003-0863-203X
Chen-Sheng YehDepartment of Chemistry, National Cheng Kung University, Tainan 701, Taiwan.ORCID 0000-0001-5102-3884

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultrasmall silver nanoclusters, Ag

Indexed as

Antineoplastic AgentsInfrared RaysMetal NanoparticlesReactive Oxygen SpeciesSilverAnimalsDarknessHumansHydrogen PeroxideLigandsMiceParticle SizePhotochemotherapyAntineoplastic AgentsHydrogen PeroxideLigandsReactive Oxygen SpeciesSilverchemodynamic therapyphotodynamic therapyROSself-oxygenationsilver nanoclusters

Identifiers

PMID42208022
PMCPMC13255526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.